2850
D. B. Berkowitz et al. / Tetrahedron: Asymmetry 15 (2004) 2845–2851
Ni(0)-mediated C–C bond forming reactions, with an
eye toward PHOX ligand performance. Interestingly,
Chem. Soc. 2002, 124, 12–13, (A Pd(II) cycle is proposed
here); (b) Trost, B. M.; Bunt, R. C.; Lemoine, R. C.;
Calkins, T. L. J. Am. Chem. Soc. 2000, 122, 5968–5976; (c)
Larksarp, C.; Alper, H. J. Am. Chem. Soc. 1997, 119,
3709–3715; (d) Hayashi, T.; Yamamoto, A.; Ito, Y.
Tetrahedron Lett. 1988, 29, 99–102.
PHOX ligands (i) perform poorly in MoriÕs R Zn-initi-
2
2
9
ated carboxylative bis-diene cyclizations, (ii) provide
modest eeÕs in UemuraÕs allylic substitutions involving
hard RMgX or arylboronate-ate nucleophiles, and
3
0
8
9
. Matsushima, Y.; Onitsuka, K.; Kondo, T.; Mitsudo, T.;
Takahashi, S. J. Am. Chem. Soc. 2001, 123, 10406–10495.
. (a) Leitner, A.; Shu, C.; Hartwig, J. F. Proc. Natl. Acad.
Sci. U.S.A. 2004, 101, 5830–5833; (b) Kiener, C. A.; Shu,
C.; Incarvito, C.; Hartwig, J. F. J. Am. Chem. Soc. 2003,
125, 14272–14273; (c) Ohmura, T.; Hartwig, J. F. J. Am.
Chem. Soc. 2002, 124, 15164–15165.
0. (a) Welter, C.; Koch, O.; Lipowsky, G.; Helmchen, G.
Chem. Commun. 2004, 896–897; (b) Lipowsky, G.; Helm-
chen, G. Chem. Commun. 2004, 116–117; (c) Bartels, B.;
Garcia-Yebra, C.; Rominger, F.; Helmchen, G. Eur. J.
Inorg. Chem. 2002, 2569–2586.
(
iii) perform either brilliantly (high conversions and
eeÕs with dinaphthothiophenes) or not at all (with
dibenzothiophenes) in HayashiÕs Grignard-based fused
arylthiophene ring openings, depending on subtle nuan-
3
1
ces of substrate structure. This suggests that further
exploration of PHOX-based Ni(0)-allylic amination
chemistry across a greater expanse of substrate space
may reapdividends.
1
1
Acknowledgements
1. (a) Evans, P. A.; Robinson, J. E.; Moffett, K. K. Org. Lett.
2
001, 3, 3269–3271; (b) Evans, P. A.; Robinson, J. E. Org.
Lett. 1999, 1, 1929–1931; (c) Evans, P. A.; Robinson, J. E.;
Nelson, J. D. J. Am. Chem. Soc. 1999, 121, 6761–6762.
The authors thank the NSF (CHE-0317083) for sup-
port. D.B.B. acknowledges the Alfred P. Sloan Founda-
tion for a fellowship. This research was facilitated by
shared instrumentation grants for NMR (NIH SIG-1-
12. Ashfeld, B. L.; Miller, K. A.; Martin, S. F. Org. Lett.
004, 6, 1321–1324.
2
1
3. To our knowledge, there had not been a previous report of
asymmetric Ni(0)-mediated allylic amination, prior to our
recent findings (Ref. 2b). However, there were several
studies of non-stereocontrolled allylic aminations using
Ni(0): (a) Bricout, H.; Carpentier, J.-F.; Mortreux, A.
Tetrahedron 1998, 54, 1073–1084; (b) Bricout, H.; Car-
pentier, J.-F.; Mortreux, A. J. Chem. Soc., Chem. Com-
mun. 1995, 1863–1864; For evidence of p-allyl-nickel
intermediates, see: (c) Moberg, C. Tetrahedron Lett. 1980,
21, 4539–4542; (d) Yamamoto, T.; Ishizu, J.; Yamamoto,
A. J. Am. Chem. Soc. 1981, 103, 6863–6869; (e) Tolman,
C. A. J. Am. Chem. Soc. 1970, 92, 6785–6790; For
examples, of substrate-directed, regio- and stereoselective
Ni(0)-mediated substitutions of allylic ethers with Grig-
nard reagents, see: (f) Didiuk, M. T.; Morken, J. P.;
Hoveyda, A. H. Tetrahedron 1998, 54, 1117–1130; (g)
Farthing, C. N.; Kocovsky, P. J. Am. Chem. Soc. 1998,
120, 6661–6672.
14. Trost, B. M.; Dietsch, T. J. J. Am. Chem. Soc. 1973, 95,
8200–8201.
15. Togni, A.; Rihs, G.; Pregosin, P. S.; Ammann, C. Helv.
Chim. Acta 1990, 73, 723–732.
16. (a) Mandal, S. K.; Sigman, M. S. J. Org. Chem. 2003, 68,
7535–7537; (b) Mueller, J. A.; Sigman, M. S. J. Am. Chem.
Soc. 2003, 125, 7005–7013; (c) Mueller, J. A.; Jensen, D.
R.; Sigman, M. S. J. Am. Chem. Soc. 2002, 124,
8202–8203; (d) Jensen, D. R.; Pugsley, J. S.; Sigman, M.
S. J. Am. Chem. Soc. 2001, 123, 7475–7476.
17. (a) Bagdanoff, J. T.; Ferreira, E. M.; Stoltz, B. M. Org.
Lett. 2003, 5, 835–837; (b) Ferreira, E. M.; Stoltz, B. M. J.
Am. Chem. Soc. 2001, 123, 7725–7726.
18. (a) Mueller, T. E.; Berger, M.; Grosche, M.; Herdtweck,
E.; Schmidtchen, F. Organometallics 2001, 20, 4384–4393;
(b) Bianchini, C.; Glendenning, L.; Zanobini, F.; Farnetti,
E.; Graziani, M.; Nagy, E. J. Mol. Catal. A: Chem. 1998,
132, 13–19; (c) Bianchini, C.; Farnetti, E.; Glendenning,
L.; Graziani, M.; Nardin, G.; Peruzzini, M.; Rocchini, E.;
Zanobini, F. Organometallics 1995, 14, 1489–1502.
19. (a) Hayashi, T.; Yamamoto, K.; Kumada, M. Tetrahedron
Lett. 1974, 4405–4408; (b) Hayashi, T.; Tajika, M.;
Tamao, K.; Kumada, M. J. Am. Chem. Soc. 1976, 98,
3718–3719; (c) Fernandez-Galan, R.; Jalon, F. A.; Manz-
ano, B. R.; Rodriguez-de la Fuente, J.; Vrahami, M.;
Jedlicka, B.; Weissensteiner, W.; Jogl, G. Organometallics
1997, 16, 3758–3768; (d) Cammidge, A. N.; Crepy, K. V. L.
5
0
10-RR-06301, NSF CHE-0091975, NSF MRI-
079750) and GC/MS (NSF CHE-9300831),
respectively.
References
1
. Reviews: (a) Reetz, M. T. Compr. Coord. Chem. II 2004, 9,
09–548; (b) Stambuli, J. P.; Hartwig, J. F. Curr. Opin.
5
Chem. Biol. 2003, 7, 420–426; (c) Traverse, J. F.; Snapper,
M. L. Drug Discovery Today 2002, 7, 1002–1012; (d) Finn,
M. G. Chirality 2002, 14, 534–540; (e) Reetz, M. T. Angew.
Chem., Int. Ed. 2002, 41, 1335–1338; (f) Loch, J. A.;
Crabtree, R. H. Pure Appl. Chem. 2001, 73, 119–128.
. (a) Berkowitz, D. B.; Bose, M.; Choi, S. Angew. Chem.,
Int. Ed. 2002, 41, 1603–1607; (b) Berkowitz, D. B.; Maiti,
G. Org. Lett. 2004, 6, 2661–2664.
. For examples, of the use of enzymes to analyze chiral
reaction products, post work-up, see: (a) Abato, P.; Seto,
C. T. J. Am. Chem. Soc. 2001, 123, 9206–9207; (b) Onaran,
M. B.; Seto, C. T. J. Org. Chem. 2003, 68, 8136–8141; (c)
Li, Z.; Buetikofer, L.; Witholt, B. Angew. Chem., Int. Ed.
2
3
2004, 43, 1698–1702; For related approaches, using anti-
bodies, see: (d) Matsushita, M.; Yoshida, K.; Yamamoto,
N.; Wirsching, P.; Lerner, R. A.; Janda, K. D. Angew.
Chem., Int. Ed. 2003, 42, 5984–5987; (e) Taran, F.;
Gauchet, C.; Mohar, B.; Meunier, S.; Valleix, A.; Renard,
P.-Y.; Cr e´ minon, C.; Grassi, J.; Wagner, A.; Mioskowski,
C. Angew. Chem., Int. Ed. 2002, 41, 124–127.
4
. Reviews concerning allylic amination: (a) Johannsen, M.;
Jorgensen, K. A. Chem. Rev. 1998, 98, 1708–1869; (b)
Trost, B. M. Pure Appl. Chem. 1996, 68, 779–784.
. For references on PLP–enzyme inhibition with a-vinylic
amino acids, see: Berkowitz, D. B.; Jahng, W.-J.; Peder-
sen, M. L. Bioorg. Med. Chem. Lett. 1996, 6, 2151–2156,
and references cited therein.
5
6
7
. For leading references on the stereocontrolled synthesis of
a-vinylic amino acids, see: (a) Ma, D.; Zhu, W. J. Org.
Chem. 2001, 66, 348–350; (b) Berkowitz, D. B.; McFad-
den, J. M.; Chisowa, E.; Semerad, C. L. J. Am. Chem. Soc.
2000, 122, 11031–11032; (c) Berkowitz, D. B.; McFadden,
J. M.; Sloss, M. K. J. Org. Chem. 2000, 65, 2907–2918.
. For examples, of related asymmetric allylic aminations
with Pd, see: (a) Overman, L. O.; Remarchuk, T. P. J. Am.